The aim is to test secure, cloud-based remote medical device monitoring.
Through the collaboration Aerocrine will utilize Microsoft’s cloud services to transmit device telemetry data from physician and company sites in Sweden, UK and US back to Aerocrine for analyses.
“The ability to collect vital telemetry data from deployed devices has been a key objective of ours. A cloud-based solution allowing us to collect data on device performance in real-time helps us to be more proactive in our customer support and ensure that our NIOX devices help the physicians deliver the best possible outcome for the patient,” says Scott Myers, CEO of Aerocrine.
Microsoft and Aerocrine are working together on this pilot project because of the unique ability of Aerocrine’s devices to generate data at the point of care, states Aerocrine in a press relsease. This proof of concept will be conducted this fall and will collect data from Aerocrine devices deployed in Sweden, the UK and the United States. Microsoft will connect the Aerocrine devices to its secure cloud analytics platform, Microsoft Azure in the first phase to demonstrate the secure and accurate transmission of telemetry data.
“We are excited to work with Aerocrine on this project as part of the CityNext, Healthier Cities initiative to show the potential of new technology to drive productivity and patient safety as we move towards a mobile-first and cloud-first world,” says Mathias Ekman, Industry Marketing Development Manager at Microsoft Sweden.